Pharmacological validation of early and late phase of rat mono-iodoacetate model using the Tekscan system

European Journal of Pain (United Kingdom)

Volumn 17, Issue 2, 2013, Pages 210-222

  Rashid, M H ^a   Theberge, Y ^a   Elmes, S J ^a   Perkins, M N ^a   McIntosh, F ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DEXAMETHASONE; DULOXETINE; IODOACETIC ACID; MORPHINE; NAPROXEN; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; JOINT; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SYNOVIAL FLUID; TACTILE STIMULATION; WEIGHT BEARING;

ALKYLATING AGENTS; ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRALGIA; CHRONIC DISEASE; DEXAMETHASONE; DINOPROSTONE; DISEASE MODELS, ANIMAL; HINDLIMB; IODOACETATES; MALE; MORPHINE; MUSCLE FIBERS, SKELETAL; NAPROXEN; NEURONS, AFFERENT; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; RESTRAINT, PHYSICAL; SYNOVIAL FLUID; THIOPHENES; WEIGHT-BEARING;

EID: 84873671817     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2012.00176.x     Document Type: Article

References (36)

1. Arendt-Nielsen, L., Nie, H., Laursen, M.B., Laursen, B.S., Madeleine, P., Simonsen, O.H., Graven-Nielsen, T. (2010). Sensitization in patients with painful knee osteoarthritis. Pain 149, 573-581.
2. Benito, M.J., Veale, D.J., FitzGerald, O., van den Berg, W.B., Bresnihan, B. (2005). Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 64, 1263-1267.
3. Bjordal, J.M., Klovning, A., Ljunggren, A.E., Slørdal, L. (2007). Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. Eur J Pain 11, 125-138.
4. Bove, S.E., Calcaterra, S.L., Brooker, R.M., Huber, C.M., Guzman, R.E., Juneau, P.L., Schrier, D.J., Kilgore, K.S. (2003). Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage 11, 821-830.
5. Chappell, A.S., Ossanna, M.J., Liu-Seifert, H., Iyengar, S., Skljarevski, V., Li, L.C., Bennett, R.M., Collins, H. (2009). Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial. Pain 146, 253-260.
6. Clarke, K.A., Heitmeyer, S.A., Smith, A.G., Taiwo, Y.O. (1997). Gait analysis in a rat model of osteoarthrosis. Physiol Behav 62, 951-954.
7. Clements, K.M., Ball, A.D., Jones, H.B., Brinckmann, S., Read, S.J., Murray, F. (2009). Cellular and histopathological changes in the infrapatellar fat pad in the monoiodoacetate model of osteoarthritis pain. Osteoarthritis Cartilage 17, 805-812.
8. Creamer, P., Lethbridge-Cejku, M., Hochberg, M.C. (1998). Where does it hurt? Pain localization in osteoarthritis of the knee. Osteoarthritis Cartilage 6, 318-323.
9. Dunham, J.P., Kelly, S., Donaldson, L.F. (2008). Inflammation reduces mechanical thresholds in a population of transient receptor potential channel A1-expressing nociceptors in the rat. Eur J Neurosci 27, 3151-3160.
10. Dworkin, R.H., Peirce-Sandner, S., Turk, D.C., McDermott, M.P., Gibofsky, A., Simon, L.S., Farrar, J.T., Katz, N.P. (2011). Outcome measures in placebo-controlled trials of osteoarthri-tis: Responsiveness to treatment effects in the REPORT database. Osteoarthritis Cartilage 19, 483-492.
11. Ferland, C.E., Laverty, S., Beaudry, F., Vachon, P. (2011). Gait analysis and pain response of two rodent models of osteoar-thritis. Pharmacol Biochem Behav 97, 603-610.
12. Fernihough, J., Gentry, C., Malcangio, M., Fox, A., Rediske, J., Pellas, T., Kidd, B., Bevan, S., Winter, J. (2004). Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 112, 83-93.
13. Guingamp, C., Gegout-Pottie, P., Philippe, L., Terlain, B., Netter, P., Gillet, P. (1997). Mono-iodoacetate-induced experimental osteoarthritis: A dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 40, 1670-1679.
14. Hannan, M.T., Felson, D.T., Pincus, T. (2000). Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol 27, 1513-1517.
15. Hurwitz, D.E., Ryals, A.R., Block, J.A., Sharma, L., Schnitzer, T.J., Andriacchi, T.P. (2000). Knee pain and joint loading in subjects with osteoarthritis of the knee. J Orthop Res 18, 572-579.
16. Im, H.J., Kim, J.S., Li, X., Kotwal, N., Sumner, D.R., van Wijnen, A.J., Davis, F.J., Yan, D., Levine, B., Henry, J.L., Desevré, J., Kroin, J.S. (2010). Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum 62, 2995-3005.
17. Ivanavicius, S.P., Ball, A.D., Heapy, C.G., Westwood, F.R., Murray, F., Read, S.J. (2007). Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: Increased expression of ATF-3 and pharmacological characterisation. Pain 128, 272-282.
18. Kosek, E., Ordeberg, G. (2000). Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain 88, 69-78.
19. Orita, S., Ishikawa, T., Miyagi, M., Ochiai, N., Inoue, G., Eguchi, Y., Kamoda, H., Arai, G., Toyone, T., Aoki, Y., Kubo, T., Takahashi, K., Ohtori, S. (2011). Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord 12, 134.
20. Parks, E.L., Geha, P.Y., Baliki, M.N., Katz, J., Schnitzer, T.J., Apkarian, A.V. (2011). Brain activity for chronic knee osteoarthritis: Dissociating evoked pain from spontaneous pain. Eur J Pain 15, 843.e1-843.14.
21. Pelletier, J.P., DiBattista, J.A., Raynauld, J.P., Wilhelm, S., Martel-Pelletier, J. (1995). The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 72, 578-586.
22. Pomonis, J.D.M., Boulet, J.M., Gottshall, S.L., Phillips, S., Rani, S., Bunton, T., Walker, K. (2005). Development and pharmacological characterisation of a rat model of osteoarthritis pain. Pain 114, 339-346.
23. Pulichino, A.M., Rowland, S., Wu, T., Clark, P., Xu, D., Mathieu, M.C., Riendeau, D., Audoly, L.P. (2006). Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis. J Pharmacol Exp Ther 319, 1043-1050.
24. Puttfarcken, P.S., Han, P., Joshi, S.K., Neelands, T.R., Gauvin, D.M., Baker, S.J., Lewis, L.G., Bianchi, B.R., Mikusa, J.P., Koenig, J.R., Perner, R.J., Kort, M.E., Honore, P., Faltynek, C.R., Kym, P.R., Reilly, R.M. (2010). A-995662[(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1, 2, 3,-4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model. Pain 150, 319-326.
25. Read, S.J., Dray, A. (2008). Osteoarthritic pain: A review of current, theoretical and emerging therapeutics. Expert Opin Investig Drugs 17, 619-640.
26. Sagar, D.R., Staniaszek, L.E., Okine, B.N., Woodhams, S., Norris, L.M., Pearson, R.G., Garle, M.J., Alexander, S.P., Bennett, A.J., Barrett, D.A., Kendall, D.A., Scammell, B.E., Chapman, V. (2010). Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain. Arthritis Rheum 62, 3666-3676.
27. Sarzi-Puttini, P., Cimmino, M.A., Scarpa, R., Caporali, R., Parazzini, F., Zaninelli, A., Atzeni, F., Canesi, B. (2005). Osteoarthritis: An overview of the disease and its treatment strategies. Semin Arthritis Rheum 35(1 Suppl 1), 1-10.
28. Schuelert, N., McDougall, J.J. (2009). Grading of monosodium iodoacetate-induced osteoarthritis reveals a concentrationdependent sensitization of nociceptors in the knee joint of the rat. Neurosci Lett 465, 184-188.
29. Stein, A., Yassouridis, A., Szopko, C., Helmke, K., Stein, C. (1999). Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 83, 525-532.
30. Sullivan, M.D., Bentley, S., Fan, M.Y., Gardner, G. (2009). A single-blind, placebo run-in study of duloxetine for activitylimiting osteoarthritis pain. J Pain 10, 208-213.
31. Swearingen, C.A., Chambers, M.G., Lin, C., Marimuthu, J., Rito, C.J., Carter, Q.L., Dotzlaf, J., Liu, C., Chandrasekhar, S., Duffin, K.L., Mitchell, P.G., Durham, T.B., Wiley, M.R., Thirunavukkarasu, K. (2010). A short-term pharmacodynamic model for monitoring aggrecanase activity: Injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs. Osteoarthritis Cartilage 18, 1159-1166.
32. Tannenbaum, H., Berenbaum, F., Reginster, J.Y., Zacher, J., Robinson, J., Poor, G., Bliddal, H., Uebelhar, D., Adami, S., Navarro, F., Lee, A., Moore, A., Gimona, A. (2004). Lumiracoxib is effective in the treatment of osteoarthritis of the knee: A 13-week, randomized, double-blind study versus placebo and celecoxib. Ann Rheum Dis 63, 1419-1426.
33. Tétreault, P., Dansereau, M.A., Doré-Savard, L., Beaudet, N., Sarret, P. (2011). Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats. Physiol Behav 104, 495-502.
34. van der Kraan, P.M., Vitters, E.L., van de Putte, L.B.A., van den Berg, W. (1989). Development of osteoarthritic lesions in mice by 'metabolic' and 'mechanical' alterations in the knee joints. Am J Pathol 135, 1001-1014.
35. Vane, J.R., Botting, R.M. (1997). Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47, S78-S87.
36. Vonsy, J.L., Ghandehari, J., Dickenson, A.H. (2009). Differential analgesic effects of morphine and gabapentin on behavioural measures of pain and disability in a model of osteoarthritis pain in rats. Eur J Pain 13, 786-793.